![Global Cancer Immunotherapy Market](https://res.cloudinary.com/devmoveo/image/upload/v1706607512/skyquest/report/php3NJPKx.jpg)
Report ID: SQMIG35I2296
Report ID:
SQMIG35I2296 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
120 |
Figures:
69
Globally, North America dominated the cancer immunotherapy market with a healthy market share in 2021 due to the rising incidence of diseases, adoption to high technology devices, and growing geriatric population. Additionally, growing number of biotechnology companies and continuously rising development activities coupled with the high consumer income, are some other factors projected to drive the growth of the market in the region over the coming years.
Furthermore, Asia Pacific is witnessing fastest CAGR during the forecast period owing to introduction to new and advanced immunotherapy drugs in countries like India and China with increasing number of clinical trials in the region. Moreover, rising government efforts to improve the healthcare infrastructure and product development especially in emerging economies such as India, China, and Brazil, are also likely to boost the demand for cancer immunotherapy services in the region.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONCancer Immunotherapy Market size was valued at USD 39.05 billion in 2019 and is poised to grow from USD 85.6 billion in 2023 to USD 309.67 billion by 2031, growing at a CAGR of 9.6% in the forecast period (2024-2031).
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35I2296